What studies exist on GLP-1 receptor agonist medications and their effects on addiction, including smoking, drugs, and alcohol?
Evidence shows that GLP-1 receptor agonists may reduce consumption and cravings related to alcohol, tobacco, and a variety of other substance use disorders, though more high-quality trials are needed to confirm these findings.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24366476
- Primary Topic
- Substance Abuse Treatment and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00